Skyviews is a privately held advisory company specialised in precision health and longevity. We identify investment opportunities at the growing interface between biotechnology, advanced nutrition and digital health.

We target private and public companies with better drugs, advanced technology platforms, preventive strategies, personalized solutions and more natural foods that will improve people’s quality of life. We are a team of experienced professionals from the academic, corporate, consumer and venture capital sectors. We leverage worldwide networks and work closely with partner organizations to identify outstanding value for our clients, for patients, for healthcare payors and for capital. Our perspective is rooted in “P4 medicine”, evolving from reactive disease care to care that is predictive, preventive, personalized and participatory. This new paradigm focuses on big data, better lifestyles and tailored treatments, building on the evidence that each individual’s health experience is unique.